Jörg L - Search Results

1

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.

Vogt AS, Jörg L, Martina B, Krenger PS, Chang X, Zeltins A, Vogel M, Mohsen MO, Bachmann MF. Vogt AS, et al. Among authors: jorg l. Front Immunol. 2022 Jun 16;13:864718. doi: 10.3389/fimmu.2022.864718. eCollection 2022. Front Immunol. 2022. PMID: 35784292 Free PMC article.

2

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.

Bitzenhofer M, Suter-Riniker F, Moor MB, Sidler D, Horn MP, Gschwend A, Staehelin C, Rauch A, Helbling A, Jörg L. Bitzenhofer M, et al. Among authors: jorg l. PLoS One. 2022 Jun 9;17(6):e0268780. doi: 10.1371/journal.pone.0268780. eCollection 2022. PLoS One. 2022. PMID: 35679232 Free PMC article.

3

IgE glycosylation is essential for the function of omalizumab.

Plattner K, Augusto G, Muerner L, von Gunten S, Jörg L, Engeroff P, Bachmann MF, Vogel M. Plattner K, et al. Among authors: jorg l. Allergy. 2023 Sep;78(9):2546-2549. doi: 10.1111/all.15748. Epub 2023 Apr 28. Allergy. 2023. PMID: 37073887 Free article. No abstract available.

4

The Activation Pattern of Drug-Reacting T Cells Has an Impact on the Clinical Picture of Hypersensitivity Reactions.

Wuillemin N, Ballmer-Weber B, Schlapbach C, Jörg L, Yerly D. Wuillemin N, et al. Among authors: jorg l. Front Allergy. 2022 Feb 21;3:804605. doi: 10.3389/falgy.2022.804605. eCollection 2022. Front Allergy. 2022. PMID: 35386648 Free PMC article.

5

Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.

Jörg L, Pecaric-Petkovic T, Reichenbach S, Coslovsky M, Stalder O, Pichler W, Hausmann O. Jörg L, et al. Clin Exp Allergy. 2018 Feb;48(2):196-204. doi: 10.1111/cea.13066. Epub 2017 Dec 12. Clin Exp Allergy. 2018. PMID: 29164723 Clinical Trial.

6

A novel functional mast cell assay for the detection of allergies.

Zbären N, Brigger D, Bachmann D, Helbling A, Jörg L, Horn MP, Schmid JM, Hoffmann HJ, Kinet JP, Kaufmann T, Eggel A. Zbären N, et al. Among authors: jorg l. J Allergy Clin Immunol. 2022 Mar;149(3):1018-1030.e11. doi: 10.1016/j.jaci.2021.08.006. Epub 2021 Aug 18. J Allergy Clin Immunol. 2022. PMID: 34418424 Free article.

7

Multiple drug hypersensitivity syndrome (MDH) should not be diagnosed by drug provocation tests.

Jörg L, Yerly D, Pichler W. Jörg L, et al. J Allergy Clin Immunol Pract. 2020 Feb;8(2):822-823. doi: 10.1016/j.jaip.2019.10.050. J Allergy Clin Immunol Pract. 2020. PMID: 32037118 No abstract available.

8

Das Kreuz mit der Kreuzallergie: Betalaktamantibiotika-Allergie.

Jörg L, Helbling A. Jörg L, et al. Ther Umsch. 2019 Jul;75(1):7-11. doi: 10.1024/0040-5930/a001055. Ther Umsch. 2019. PMID: 31282836 German.

9

The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome.

Jörg L, Yerly D, Helbling A, Pichler W. Jörg L, et al. Allergy. 2020 May;75(5):1178-1187. doi: 10.1111/all.14146. Epub 2020 Jan 1. Allergy. 2020. PMID: 31814130 Free article.

10

IgE-mediated chlorhexidine allergy-Cross-reactivity with other biguanide disinfectants.

Mueller-Wirth N, Buenter A, Jörg L, Ebo DG, Glatz M, Fernando SL, Spoerl D, Helbling A, Hausmann O, Gupta N, Pichler WJ. Mueller-Wirth N, et al. Among authors: jorg l. Allergy. 2020 Dec;75(12):3237-3247. doi: 10.1111/all.14497. Epub 2020 Aug 5. Allergy. 2020. PMID: 32678912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page